# Probiotic Use for Recovery Enhancement From Long COVID-19

> **NCT06643299** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Rush University Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Post-Acute COVID-19 Syndrome

## Interventions

- **DRUG:** Probiotic Agent
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06643299
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2026-05
- **Final completion:** 2026-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06643299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06643299, "Probiotic Use for Recovery Enhancement From Long COVID-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06643299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*